Phase 3 Randomized Study of SB5, an Adalimumab Biosimilar,...

  • Main
  • 2017 / 09
  • Phase 3 Randomized Study of SB5, an Adalimumab Biosimilar,...
Arthritis & Rheumatology 2017 / 09

Phase 3 Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate to Severe Rheumatoid Arthritis

Weinblatt, Michael E., Baranauskaite, Asta, Niebrzydowski, Jaroslaw, Dokoupilova, Eva, Zielinska, Agnieszka, Jaworski, Janusz, Racewicz, Artur, Pileckyte, Margarita, Jedrychowicz-Rosiak, Krystyna, Che
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Arthritis & Rheumatology
DOI:
10.1002/art.40336
Date:
September, 2017
File:
PDF, 374 KB
english, 2017
Conversion to is in progress
Conversion to is failed